Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Farmaco (Societa Chimica Italiana : 1989)|June 17, 1999
Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3P Sanna, A Carta, M Loriga, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 7, 2002
Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agentsA Carta, P Sanna, L Gherardini, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 1, 1997
Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activityM Loriga, P Moro, P Sanna, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 17, 1999
Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2P Sanna, A Carta, M Loriga, et al.
Oncology Reports|May 9, 1998
Primary extranodal lymphoma of skeletal muscles: a report of four casesF Bertoni, P Sanna, E Zucca, et al.
Farmaco (Societa Chimica Italiana : 1989)|July 1, 1992
1,2,3-triazolo[4,5-h]quinolines. III. Preparation and antimicrobial evaluation of 4-ethyl-4,7-dihydro-1(2)-R-1(2)H triazolo[4,5-h]quinolin-7-one-6-carboxylic acids as anti-infectives of the urinary tractP Sanna, A Carta, G Paglietti, et al.
Schweizerische Medizinische Wochenschrift|June 22, 1996
[Paraplegia following intrathecal chemotherapy]F Beretta, P Sanna, M Ghielmini, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 4, 1998
Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activityP Sanna, A Carta, M Loriga, et al.
Neuroscience|July 6, 2010
Protein degradation by the proteasome is required for synaptic tagging and the heterosynaptic stabilization of hippocampal late-phase long-term potentiationF Cai, J U Frey, P P Sanna, et al.
Schweizerische Medizinische Wochenschrift|January 15, 1999
High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphomaP Sanna, S Van den Bosch, F Cavalli, et al.
Pageof 10